| Financial Year |
March 31 2023 |
| Monetary Funds |
1,381,951,835.56 |
| Held-for-trading Financial Assets |
399,602,419.76 |
| Notes Receivable |
7,695,786.07 |
| Accounts Receivable |
274,536,175.13 |
| Advances to Suppliers |
2,506,672.59 |
| Other Receivables |
12,598,216.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
503,639,188.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,444,986.73 |
| Total Current Assets |
2,671,296,896.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,134,650.87 |
| Investment Properties |
336,769.76 |
| Fixed Assetes |
415,381,940.31 |
| Under-construction Projects |
425,137.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
93,480,242.22 |
| R&D expenses |
-- |
| Goodwill |
215,414,153.88 |
| Long-Term Deferred and Prepaid Expenses |
37,564,804.64 |
| Deferred Income Tax Assets |
10,406,368.76 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
809,541,634.54 |
| Total Assets |
3,480,838,531.20 |
| Short-Term Loans |
1,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
100,043,918.03 |
| Accounts Payable |
95,413,398.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,479,532.03 |
| Taxes Payable |
9,927,624.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,489,943.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,360,938.79 |
| Other Current Liabilities |
824,548.08 |
| Sub-Total of Current Liabilities |
281,631,591.05 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,375,651.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
34,674,375.03 |
| Total Liabilities |
316,305,966.08 |
| Paid-In Capital(Or Share Stock) |
462,609,137.00 |
| Capital Surplus |
1,008,020,359.26 |
| Surplus Reserve |
236,734,344.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,451,376,328.40 |
| Minority Stockholder's Interest |
5,873,164.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,158,659,400.97 |
| Owner's Equity（Stockholder's Equity） |
3,164,532,565.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,480,838,531.20 |
